The asymmetric Henry reaction as synthetic tool for production of drugs Linezolid and Rivaroxaban

Submitting author affiliation:
University of Pardubice, Pardubice, Czech Republic

Beilstein Arch. 2022, 20224.

Published 17 Jan 2022



The human drugs – antibiotic Linezolid (1) and anticoagulant Rivaroxaban (2) – belongs among modern pharmaceutics, which contain oxazolidine-2-one moiety bearing stereogenic centre. The chirality of these drugs is fundamental attribute of their biological activity. Herein, one of the efficient asymmetric syntheses of those drugs was studied in detail. High enantioselective catalysts were tested in the key step of the synthetic procedure, i.e. asymmetric Henry reaction, under different reaction conditions, using several starting aldehydes. The corresponding nitroaldols as chiral intermediates of those drugs were obtained in high yields and enantiomeric excess up to 91% ee.

Keywords: Asymmetric Henry reaction; Enantioselective catalysis; Linezolid; Oxazolidine-2-one derivatives; Rivaroxaban

Supporting Information

Format: DOCX Size: 12.6 MB   Download

How to Cite

When a peer-reviewed version of this preprint is available, this information will be updated in the information box above. If no peer-reviewed version is available, please cite this preprint using the following information:

Vrbický, M.; Macek, K.; Pochobradský, J.; Svoboda, J.; Sedlák, M.; Drabina, P. Beilstein Arch. 2022, 20224. doi:10.3762/bxiv.2022.4.v1

Download citation
Download RIS (Reference Manager) Download BIB (BIBTEX)

© 2022 Vrbický et al.; licensee Beilstein-Institut.
This is an open access work licensed under the terms of the Beilstein-Institut Open Access License Agreement (, which is identical to the Creative Commons Attribution 4.0 International License ( The reuse of material under this license requires that the author(s), source and license are credited. Third-party material in this work could be subject to other licenses (typically indicated in the credit line), and in this case, users are required to obtain permission from the license holder to reuse the material.